News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tornier And BioSET Enter Synthetic Growth Factor Pact



2/6/2008 8:38:49 AM

EDINA, Minn.--(BUSINESS WIRE)--Tornier, Inc., a global leader in extremities orthopedics, announced today that it has entered into an exclusive world-wide technology collaboration in the field of orthopedic soft tissue repair with BioSurface Engineering Technologies, Inc. ("BioSET") to develop, commercialize, and distribute products that will incorporate BioSET’s synthetic growth factor technology. The collaboration will focus initially on ligament and tendon repair products that will feature coatings based on BioSET’s proprietary F2A synthetic growth factor technology (“F2A”).

Read at BioSpace.com


comments powered by Disqus
BioSET
Tornier
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES